These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35693801)

  • 41. Single cell RNA sequencing reveals distinct clusters of Irf8-expressing pulmonary conventional dendritic cells.
    Jirmo AC; Grychtol R; Gaedcke S; Liu B; DeStefano S; Happle C; Halle O; Monteiro JT; Habener A; Breiholz OD; DeLuca D; Hansen G
    Front Immunol; 2023; 14():1127485. PubMed ID: 37251386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The transcription factor Zeb1 controls homeostasis and function of type 1 conventional dendritic cells.
    Wang Y; Zhang Q; He T; Wang Y; Lu T; Wang Z; Wang Y; Lin S; Yang K; Wang X; Xie J; Zhou Y; Hong Y; Liu WH; Mao K; Cheng SC; Chen X; Li Q; Xiao N
    Nat Commun; 2023 Oct; 14(1):6639. PubMed ID: 37863917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain.
    Bowman-Kirigin JA; Desai R; Saunders BT; Wang AZ; Schaettler MO; Liu CJ; Livingstone AJ; Kobayashi DK; Durai V; Kretzer NM; Zipfel GJ; Leuthardt EC; Osbun JW; Chicoine MR; Kim AH; Murphy KM; Johanns TM; Zinselmeyer BH; Dunn GP
    Cancer Immunol Res; 2023 Jan; 11(1):20-37. PubMed ID: 36409838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rat cytomegalovirus-encoded γ-chemokine vXCL1 is a highly adapted, species-specific agonist for rat XCR1-positive dendritic cells.
    Bauer A; Madela J; Berg C; Daugvilaite V; Gurka S; Mages HW; Kroczek RA; Rosenkilde MM; Voigt S
    J Cell Sci; 2019 Nov; 133(5):. PubMed ID: 31649144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negligible Role for Deletion Mediated by cDC1 in CD8
    MacNabb BW; Kline DE; Albright AR; Chen X; Leventhal DS; Savage PA; Kline J
    J Immunol; 2019 May; 202(9):2628-2635. PubMed ID: 30902900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conservation of a chemokine system, XCR1 and its ligand, XCL1, between human and mice.
    Yamazaki C; Miyamoto R; Hoshino K; Fukuda Y; Sasaki I; Saito M; Ishiguchi H; Yano T; Sugiyama T; Hemmi H; Tanaka T; Hamada E; Hirashima T; Amakawa R; Fukuhara S; Nomura S; Ito T; Kaisho T
    Biochem Biophys Res Commun; 2010 Jul; 397(4):756-61. PubMed ID: 20541533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Classical Type 1 Dendritic Cells Dominate Priming of Th1 Responses to Herpes Simplex Virus Type 1 Skin Infection.
    Harpur CM; Kato Y; Dewi ST; Stankovic S; Johnson DN; Bedoui S; Whitney PG; Lahoud MH; Caminschi I; Heath WR; Brooks AG; Gebhardt T
    J Immunol; 2019 Feb; 202(3):653-663. PubMed ID: 30598513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
    Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
    J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD4
    Lei X; Khatri I; de Wit T; de Rink I; Nieuwland M; Kerkhoven R; van Eenennaam H; Sun C; Garg AD; Borst J; Xiao Y
    Nat Commun; 2023 Jan; 14(1):217. PubMed ID: 36639382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A
    Koster BD; López González M; van den Hout MF; Turksma AW; Sluijter BJ; Molenkamp BG; van Leeuwen PA; Vosslamber S; Scheper RJ; van den Eertwegh AJ; van den Tol MP; Jordanova EJ; de Gruijl TD
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Saponin-based adjuvants enhance antigen cross-presentation in human CD11c
    Ho NI; Huis In 't Veld LGM; van Eck van der Sluijs J; Heuts BMH; Looman MWG; Kers-Rebel ED; van den Dries K; Dolstra H; Martens JHA; Hobo W; Adema GJ
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37612044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells.
    Bachem A; Güttler S; Hartung E; Ebstein F; Schaefer M; Tannert A; Salama A; Movassaghi K; Opitz C; Mages HW; Henn V; Kloetzel PM; Gurka S; Kroczek RA
    J Exp Med; 2010 Jun; 207(6):1273-81. PubMed ID: 20479115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy.
    Teijeira A; Garasa S; Luri-Rey C; de Andrea C; Gato M; Molina C; Kaisho T; Cirella A; Azpilikueta A; Wculek SK; Egea J; Olivera I; Rodriguez I; Rouzaut A; Verkhusha V; Valencia K; Sancho D; Berraondo P; Melero I
    Cancer Res; 2022 Dec; 82(23):4373-4385. PubMed ID: 36130020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancing the immunogenicity of cancer vaccines by harnessing CLEC9A.
    Lahoud MH; Radford KJ
    Hum Vaccin Immunother; 2022 Dec; 18(1):1873056. PubMed ID: 33625943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
    Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
    J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural killer cells and dendritic epidermal γδ T cells orchestrate type 1 conventional DC spatiotemporal repositioning toward CD8
    Ghilas S; Ambrosini M; Cancel JC; Brousse C; Massé M; Lelouard H; Dalod M; Crozat K
    iScience; 2021 Sep; 24(9):103059. PubMed ID: 34568787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A distinct stimulatory cDC1 subpopulation amplifies CD8
    Meiser P; Knolle MA; Hirschberger A; de Almeida GP; Bayerl F; Lacher S; Pedde AM; Flommersfeld S; Hönninger J; Stark L; Stögbauer F; Anton M; Wirth M; Wohlleber D; Steiger K; Buchholz VR; Wollenberg B; Zielinski CE; Braren R; Rueckert D; Knolle PA; Kaissis G; Böttcher JP
    Cancer Cell; 2023 Aug; 41(8):1498-1515.e10. PubMed ID: 37451271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells.
    Silk KM; Silk JD; Ichiryu N; Davies TJ; Nolan KF; Leishman AJ; Carpenter L; Watt SM; Cerundolo V; Fairchild PJ
    Gene Ther; 2012 Oct; 19(10):1035-40. PubMed ID: 22071967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conventional Type 1 Dendritic Cells (cDC1) in Human Kidney Diseases: Clinico-Pathological Correlations.
    Chen T; Cao Q; Wang R; Zheng G; Azmi F; Wang J; Lee VW; Wang YM; Yu H; Patel M; P'ng CH; Alexander SI; Rogers NM; Wang Y; Harris DCH
    Front Immunol; 2021; 12():635212. PubMed ID: 34054804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.